Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Teixeira

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Lab on a Chip|October 19, 2021
Use of some cost-effective technologies for a routine clinical pathology laboratoryMercedes Vázquez, Laura Anfossi, Hadar Ben-Yoav, et al.
Frontiers in Oncology|May 21, 2026
<i>ATG16L1</i> and <i>OPTN</i> as a novel prognostic gene expression signature in acute myeloid leukemia survivalAlexandra Teixeira, João M Alves, Nuria Estévez-Gómez, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2014
Gla-rich protein acts as a calcification inhibitor in the human cardiovascular systemCarla S B Viegas, Marta S Rafael, José L Enriquez, et al.
Biomed Research International|June 21, 2014
Gla-rich protein is a potential new vitamin K target in cancer: evidences for a direct GRP-mineral interactionCarla S B Viegas, Marjolein Herfs, Marta S Rafael, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 3, 2024
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trialZev A Wainberg, Yoon-Koo Kang, Keun-Wook Lee, et al.
Cureus|March 31, 2025
Real-Life Experience of HER2 (Human Epidermal Growth Factor Receptor 2)-Positive Advanced Breast Cancer Patients Treated With T-DXd (Trastuzumab Deruxtecan): A Multicentric Portuguese StudyRita Bizarro, Isabel Pazos, Alexandra Teixeira, et al.
The Lancet. Oncology|October 16, 2022
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 studyZev A Wainberg, Peter C Enzinger, Yoon-Koo Kang, et al.
Echocardiography (Mount Kisco, N.Y.)|January 24, 2025
Clinical, Analytical, and Echocardiographic Associations of Impaired Cardiorespiratory Fitness After Anthracycline Chemotherapy in Breast Cancer: EPIC Fitness StudyMariana Tinoco, Margarida Castro, Luísa Pinheiro, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Lab on a Chip|October 19, 2021
Use of some cost-effective technologies for a routine clinical pathology laboratoryMercedes Vázquez, Laura Anfossi, Hadar Ben-Yoav, et al.
Frontiers in Oncology|May 21, 2026
<i>ATG16L1</i> and <i>OPTN</i> as a novel prognostic gene expression signature in acute myeloid leukemia survivalAlexandra Teixeira, João M Alves, Nuria Estévez-Gómez, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2014
Gla-rich protein acts as a calcification inhibitor in the human cardiovascular systemCarla S B Viegas, Marta S Rafael, José L Enriquez, et al.
Biomed Research International|June 21, 2014
Gla-rich protein is a potential new vitamin K target in cancer: evidences for a direct GRP-mineral interactionCarla S B Viegas, Marjolein Herfs, Marta S Rafael, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 3, 2024
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trialZev A Wainberg, Yoon-Koo Kang, Keun-Wook Lee, et al.
Cureus|March 31, 2025
Real-Life Experience of HER2 (Human Epidermal Growth Factor Receptor 2)-Positive Advanced Breast Cancer Patients Treated With T-DXd (Trastuzumab Deruxtecan): A Multicentric Portuguese StudyRita Bizarro, Isabel Pazos, Alexandra Teixeira, et al.
The Lancet. Oncology|October 16, 2022
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 studyZev A Wainberg, Peter C Enzinger, Yoon-Koo Kang, et al.
Echocardiography (Mount Kisco, N.Y.)|January 24, 2025
Clinical, Analytical, and Echocardiographic Associations of Impaired Cardiorespiratory Fitness After Anthracycline Chemotherapy in Breast Cancer: EPIC Fitness StudyMariana Tinoco, Margarida Castro, Luísa Pinheiro, et al.
Pageof 4